To determine how the known host species -specific antigenic variation of Pneumocystis carinii would affect immune recognition, mice were immunized with either mouse-or ferret-derived P. carinii, with subsequent analysis of the immune response and the ability of the mice to resist infection after immunosuppression and challenge. Immunization with mouse-derived P. carinii produced a strong immune response to mouse but not ferret P. carinii. These mice were completely protected from P. carinii pneumonia when challenged by intratracheal inoculation with mouse P. carinii. In contrast, immunization with ferret P. carinii produced a limited antibody response to mouse P. carinii and had no protective effect. These results show that P. carinii from different host species are immunologically distinct, and any possible use of immunotherapy for P. carinii pneumonia in humans must take into consideration these biologically significant antigenic differences in P. carinii of animal origin.
Pneumocystis carinii is a unique opportunistic pathogen caresponse to P. carinii from another? This issue is particularly relevant to the development of diagnostic assays or immunopable of infecting a wide variety of immunosuppressed mammalian hosts. Despite the lack of major recognizable morphotherapy for P. carinii to be used in humans.
We used a T cell -depleted mouse model to determine logic differences in P. carinii obtained from different hosts, there are now clear data that P. carinii from different host whether immunization with ferret P. carinii could protect against a challenge with mouse P. carinii. We have previously species examined to date have distinct phenotypes and genotypes [1, 2] . Consistent with these host species -specific variashown, using this model, that immunization with mouse P. carinii can protect against a subsequent homologous challenge tions in P. carinii is the finding that P. carinii is not freely transmissible between different mammalian hosts [3 -5] . De- [11] . We also analyzed the antibody response to each type of P. carinii. Thus, these experiments should begin to address spite these observations, there is experimental evidence for some degree of relatedness of P. carinii infecting different the biologic significance of the distinct but somewhat related antigenic profile of P. carinii isolated from two diverse mammammalian hosts. For example, monoclonal antibodies have been identified that bind to P. carinii isolated from unrelated malian hosts. host species [1] . Furthermore, certain regions of the genes encoding glycoprotein A [1, 6] or mitochondrial rRNA [7] Materials and Methods have been shown to be highly conserved among P. carinii from different hosts. Rat P. carinii has been used as the source of
Immunizations. To obtain P. carinii for immunizations, P. carantigens to document an immune response by humans exposed inii-infected ferret or mouse lungs were homogenized as preto or infected by P. carinii [8 -10] .
viously described [11] , and the number of organisms in the homogWhile humans, presumably after exposure to human-derived enate was quantitated. There was no further purification of the P.
P. carinii, have been shown to have circulating antibodies
carinii used for immunization. Ferret P. carinii was quantitated capable of recognizing rat P. carinii, the biologic significance by counting cyst forms after staining with toluidine blue O. Mouse of these cross-reactive antigens on P. carinii is unknown. Ex-P. carinii was quantitated by counting P. carinii nuclei after stainploiting cross-reactive antigens could be important in helping ing with Diff-Quik (Baxter Healthcare, Miami) [11] . Cyst counts were used to quantitate ferret P. carinii, since trophozoite (trophic) to define host-parasite interaction. For example, could infection forms of ferret P. carinii are not as readily visualized as with or immunization with P. carinii from one host elicit an immune mouse P. carinii. In the mouse system, a nuclei count gives a value consistently 10 times higher than a count based on cyst staining only. We assumed this relationship was the same for ferret P. carinii. Thus, in the first experiment, CB-17 mice were that was immunized with a similarly prepared homogenate of nor- nii nuclei given by direct intratracheal instillation. For the second ‡ Significantly less than mice immunized with ferret P. carinii or normal ferret lung (P õ .05).
experiment, the P. carinii challenge was given 3 days after commencing cell depletion. Twenty days after challenge, mice were killed and their lungs were harvested for analysis. Antibody determinations. Responses to immunization were anwere diluted 1:50 and 1:250 in PBS containing 5% nonfat dry alyzed by ELISA and Western blotting. Two ELISAs were used, milk and placed on nitrocellulose strips overnight at room temperaone using lectin-purified P. carinii gpA and a duplicate assay using ture. After being washed, the strips were incubated for 3 h in goat a crude sonicate of P. carinii-infected lungs (''total protein'') as anti-mouse IgG/IgM conjugated to alkaline phosphatase that had the solid-phase antigen. ELISAs were done in Linbro flat-bottomed been diluted 1:2000 in PBS with 5% nonfat dry milk. The strips microtiter plates (Flow Laboratories, McLean, VA). For the gpAwere developed with Fast Red TR salt (2 mg/mL; Sigma) and specific ELISA, microtiter wells were coated with lectin-purified naphthol AS-MX phosphate (1 mg/mL; Sigma) in 0.05 M TRISmouse or ferret P. carinii gpA [12] diluted 1:10 in 0.05 M carbonHCl (pH 8.5) to detect any mouse antibody bound to the nitrocelluate buffer (pH 8.5). For a typical gpA preparation, this would lose strips. result in a protein concentration of Ç1-10 mg/mL. The crude total
Statistics. ELISA values were compared by Student's t test. protein P. carinii antigen preparation was used to coat the wells Differences in the mean number of P. carinii among the 3 groups of the second ELISA plate. This preparation was produced by were compared by Kruskal-Wallis one-way analysis of variance on sonicating P. carinii-infected mouse or ferret lungs and then clariranks pairwise multiple comparison procedures (Dunn's method). fying the supernatant by centrifugation and microfiltration (0.45
Differences with P £ .05 were considered significant. mm pore size). This material was diluted to a protein concentration of Ç10 mg/mL in carbonate buffer and then used to coat the microtiter wells. The plates were incubated tightly covered in a Results moist chamber at 37ЊC for 90 min to allow the antigens to adhere. Coated wells were blocked with 5% commercial nonfat dry milk
To determine whether immunization with ferret P. carinii in PBS for 1 h at 37ЊC or overnight at 4ЊC. Sera were diluted 1:50 could protect against experimental challenge with a heteroloin PBS containing 0.05% Tween 20 (PBS-T; Sigma, St. Louis), gous strain (mouse) of P. carinii, immunized animals were T and 50 mL/well of each serum sample was incubated overnight at cell -depleted and challenged with viable mouse P. carinii. As
4ЊC. Plates were then washed three times with PBS-T, and bound
we have previously demonstrated [11] , mice immunized with antibody was detected using goat anti-mouse IgG/IgM conjugated mouse-derived P. carinii were protected from an intratracheal to alkaline phosphatase (Jackson ImmunoResearch Laboratories, challenge with P. carinii (table 1) . In stark contrast, the immuWest Grove, PA) diluted 1:5000 in PBS-T. After a 4-h period of nization with ferret P. carinii had no effect in preventing PCP incubation at 37ЊC, the plates were washed four times with PBSafter the challenge with mouse-derived organisms. The number T and developed by the addition of p-nitrophenyl phosphate of organisms present in the lungs of the ferret P. carinii -(Sigma) at a concentration of 1 mg/mL in diethanolamine buffer.
immunized animals was identical to that noted in the normal These ELISAs have been standardized by use of a variety of monoclonal or polyclonal antibodies known to be specific for P. carinii.
ferret lung -immunized group. Furthermore, the number of orIrrelevant monoclonal antibodies give optical densities of õ0.05
ganisms present in these latter 2 groups was typical of that in both of these ELISA formats. All samples from each experiment observed in unimmunized T cell -depleted CB-17 mice [11] .
were run at the same time and included both mouse and ferret P.
The route of immunization had no effect in these experiments, carinii-specific monoclonal antibodies to serve as controls.
with both intratracheal and ip immunization producing similar
Western blotting was done as previously described [13] to conresults.
firm results obtained by ELISA. For these studies, P. cariniiAs expected, both ferret and mouse P. carinii were immunoinfected lung homogenates were solubilized by boiling for 10 min genic when inoculated into normal CB-17 mice (table 2) . Howin SDS-PAGE sample buffer and electrophoresed through a 10% ever, the most striking result was the highly restricted immune polyacrylamide gel, and then the separated antigens were transresponse elicited by immunization with either mouse or ferret ferred to nitrocellulose as previously described [13] . production of little antibody capable of cross-reacting with carinii antigens following immunization with ferret P. carinii (figure 1B). mouse P. carinii antigens, and similarly, immunization with mouse P. carinii did not elicit a significant antibody response Figure 1 also demonstrates that both ferret P. carinii -immunized (lanes 2) and normal ferret lung -immunized (lanes 3) to ferret P. carinii. Table 2 shows the gpA and P. carinii total protein ELISA results obtained after ip immunization.
mice have weak reactivity with what appears to be mouse P. carinii gpA. This is most likely the result of natural environImmunization of mice with mouse P. carinii produced a strong antibody response to mouse P. carinii gpA, but the antibody response to ferret P. carinii gpA in these same mice was no different from that seen in the control (normal ferret lung) immunized mice. Immunization with ferret P. carinii resulted in a strong response to ferret P. carinii gpA, with no significant response to mouse gpA. Similar results were found using the total protein P. carinii preparations in the ELISA in place of gpA. However, immunization with ferret P. carinii did produce a weak antibody response to the mouse P. carinii crude antigen preparation that was slightly higher than that observed in animals immunized with normal ferret lung (P Å .06). Analysis of the various responses to the crude extract of ferret P. carinii was confounded by the response of the control and ferret P. carinii -immunized mice to ferret lung antigens. Nonetheless, there was a demonstrable antibody response to the crude ferret P. carinii antigens after immunization with ferret P. carinii but little or no antibody response to the ferret P. carinii antigens after immunization with mouse P. carinii. Similar results were observed in mice immunized by the intratracheal route (experiment 1; data not shown).
Western blots were done to confirm the serologic results obtained by ELISA. Pooled sera from the 6 animals immunized ip with mouse P. carinii contained specific antibodies that bound to a variety of mouse P. carinii antigens ( figure 1A,  lanes 1 ). In contrast, sera from the animals immunized ip with ferret P. carinii had antibodies that recognized fewer mouse we have previously demonstrated, immunization with mouse P. carinii does protect in this system [11] . The fact that there was little immunologic cross-reactivity between P. carinii gpA of ferret and mouse origin was not surprising. We have previously shown that those two molecules demonstrate host species -specific antigenic variation such that organisms can be serotyped with regard to host of origin on nii gpA [15] . What was unexpected was the inability to detect Monoclonal antibody 88-2-IH2, specific for significant immunologic cross-reactivity to antigens common ferret P. carinii gpA, is shown for comparabetween P. carinii of mouse and ferret origin. These data protive purposes.
vide additional evidence for diversity among P. carinii from different host species and, together with the finding that P. carinii are not freely transmissible among different mammalian hosts [3 -5] , demonstrate further that P. carinii from different hosts are biologically and immunologically distinct. Elucidating the nature of this close association of P. carinii with a particular host will be difficult but likely important in fully understanding the life cycle of this organism.
The antigens of P. carinii are not well-characterized, but mental exposure to mouse P. carinii rather than the result of serologic (using monoclonal antibodies) and molecular analysis immunization, for the following two reasons. The immunized [1, 2] indicates that there are some shared epitopes among mice were conventionally housed, rather than barrier isolated, P. carinii from different host species. However, the results so cages were frequently open to the environment, such as described here indicate that when presented in the context of during feeding or bedding changes. In addition, both the ferret the whole organism, these conserved moieties do not elicit a P. carinii -and normal ferret lung -immunized mice show the strong immune response. This is consistent with the fact that same pattern of reactivity, making it less likely that the obfew monoclonal antibodies have been produced that react with served antibodies were the result of exposure to ferret P. carinii. P. carinii from more than one host species [1] . Likewise, whatWe did not do a similar Western blot analysis using ferret ever the antigens responsible for eliciting the protective im-P. carinii antigens immobilized on nitrocellulose because of mune response observed in our mouse model, they appear to the confounding presence of antibodies to normal ferret lung induce a protective immune response that is specific to mouse antigens. However, by using only lectin-purified ferret P. cari-P. carinii. nii gpA as the immobilized antigen for Western blot, we were There are several potential implications of these results with able to confirm the ELISA results in that the ferret P. cariniiregard to PCP in humans. First, for lack of better alternatives, immunized mice reacted with ferret P. carinii gpA, whereas rat P. carinii have often been used for serologic analysis of those immunized with mouse P. carinii or normal ferret lung human immune responses to P. carinii [8 -10] . However, our did not (figure 2). data suggest that for the most accurate results, P. carinii of human origin should be used as the target in immunoassays of human samples. A second implication of the observed results Discussion is more theoretical and has to do with the development of immunotherapy of PCP [11] . If the results obtained in animal The purpose of these experiments was to try to better define the antigenic relationship between P. carinii isolated from two models are to be translated to clinical practice, vaccines (or immunoglobulin preparations) based on human P. carinii antidiverse host species and to determine the biologic relevance of these antigenic differences with regard to the immunopathogens will almost certainly be required. Finally, a good antigen detection assay system is still needed for use in the diagnosis genesis of PCP. By immunizing mice with mouse or ferret P. carinii, we were able to observe that the immune system of of PCP, and if an immunologic detection system is to be developed, it should use antigens known to be recognized after the mouse responded as if these two types of P. carinii were quite distinct organisms. Not only was little cross-reactive antiinfection by human P. carinii. Given the clear immunologic distinction observed between body detected in our immunoassays, but the lack of functional immune cross-reaction was evidenced by the complete failure ferret and mouse P. carinii, it is surprising that humans do have circulating antibodies capable of recognizing rat P. carinii. The of immunization with ferret P. carinii to protect susceptible mice from a challenge with mouse P. carinii. In contrast, as reason why antibody to rat P. carinii is detectable in human
